PRESS RELEASE published on 03/23/2026 at 07:30, 4 months 11 days ago Informations privilégiées / Autres communiqués Sensorion publie les données à six mois de l’essai clinique de Phase 1/2 Audiogene pour SENS-501 et poursuit le développement clinique du GJB2-GT (SENS-601) vers une première administration chez l’homme Essai Clinique Thérapie Génique Sensorion Surdité GJB2-GT
BRIEF published on 03/18/2026 at 07:35, 4 months 16 days ago Sensorion publie ses résultats 2025 et les dernières nouvelles de l'entreprise Résultats Financiers Thérapie Génique Sensorion Perte Auditive Investissements Sanofi
BRIEF published on 03/18/2026 at 07:35, 4 months 16 days ago Sensorion Reports 2025 Results and Corporate Updates Financial Results Gene Therapy Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 03/18/2026 at 07:30, 4 months 16 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats annuels 2025, met à jour sa feuille de route et annonce la publication du rapport annuel, avec des avancées significatives dans les thérapies géniques pour la perte auditive Résultats Annuels Bilan Financier Thérapies Géniques Sensorion Perte Auditive
PRESS RELEASE published on 03/18/2026 at 07:30, 4 months 16 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2025 results, provides corporate update, and announces release of annual report. Key milestones in gene therapies for hearing loss. Financial highlights and future expectations highlighted Financial Highlights Full-year Results Sensorion Gene Therapies Future Milestones
BRIEF published on 02/17/2026 at 07:35, 5 months 14 days ago Sensorion annonce des changements dans sa direction Sensorion Changement Direction Thérapie Auditive Financement Sanofi Pipeline Médical
BRIEF published on 02/17/2026 at 07:35, 5 months 14 days ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
BRIEF published on 02/17/2026 at 07:35, 5 months 14 days ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 5 months 14 days ago Transition de direction chez Sensorion dans un contexte de recentrage stratégique sur les thérapies contre la perte auditive Biotechnologie Thérapie Génique Changement De Leadership Sensorion Perte Auditive
PRESS RELEASE published on 02/17/2026 at 07:30, 5 months 14 days ago Informations privilégiées / Autres communiqués Sensorion annonce des changements dans sa direction avec le départ de Nawal Ouzren et la prise de fonction par Amit Munshi en tant que Directeur Général par intérim Direction Sensorion Changements Amit Munshi Nawal Ouzren
Published on 08/01/2026 at 01:58, 2 days 6 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 2 days 7 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 7 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 8 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 08:30, 10 minutes ago Suspension - The Hospital Company (Dartford) Issuer PLC
Published on 08/03/2026 at 08:29, 11 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 08:29, 11 minutes ago Lancement d’une tranche de 225 millions d’euros du programme de rachat d’actions
Published on 08/03/2026 at 07:00, 1 hour 40 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 08/03/2026 at 07:00, 1 hour 40 minutes ago Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Published on 07/31/2026 at 21:00, 2 days 11 hours ago Carrefour finalise la vente de sa participation minoritaire dans CarrefourSA en Turquie à Yeni Mağazacılık A.Ş., société opérant l'enseigne de A101 et contrôlée par le Groupe Aydın
